Spandidos Publications style
Miyata Y, Araki K, Ohba K, Mastuo T, Nakamura Y, Yuno T, Mukai Y, Otsubo A, Mitsunari K, Mochizuki Y, Mochizuki Y, et al: [Corrigendum] Oral intake of royal jelly improves anti‑cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF‑α and TGF‑β in renal cell carcinoma: A preliminary study based on a randomized double‑blind clinical trial. Mol Clin Oncol 13: 78, 2020.
APA
Miyata, Y., Araki, K., Ohba, K., Mastuo, T., Nakamura, Y., Yuno, T. ... Sakai, H. (2020). [Corrigendum] Oral intake of royal jelly improves anti‑cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF‑α and TGF‑β in renal cell carcinoma: A preliminary study based on a randomized double‑blind clinical trial. Molecular and Clinical Oncology, 13, 78. https://doi.org/10.3892/mco.2020.2148
MLA
Miyata, Y., Araki, K., Ohba, K., Mastuo, T., Nakamura, Y., Yuno, T., Mukai, Y., Otsubo, A., Mitsunari, K., Mochizuki, Y., Sakai, H."[Corrigendum] Oral intake of royal jelly improves anti‑cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF‑α and TGF‑β in renal cell carcinoma: A preliminary study based on a randomized double‑blind clinical trial". Molecular and Clinical Oncology 13.6 (2020): 78.
Chicago
Miyata, Y., Araki, K., Ohba, K., Mastuo, T., Nakamura, Y., Yuno, T., Mukai, Y., Otsubo, A., Mitsunari, K., Mochizuki, Y., Sakai, H."[Corrigendum] Oral intake of royal jelly improves anti‑cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF‑α and TGF‑β in renal cell carcinoma: A preliminary study based on a randomized double‑blind clinical trial". Molecular and Clinical Oncology 13, no. 6 (2020): 78. https://doi.org/10.3892/mco.2020.2148
